Combination of a mcl-1 inhibitor and midostaurin, uses and pharmaceutical compositions thereof
US-2022016118-A1 · Jan 20, 2022 · US
This page is not indexed by search engines while we improve data quality.
Wang Youzhen patents
Wang Youzhen is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wang Youzhen |
| Total patents | 7 |
| First publication | Jul 5, 2018 |
| Latest publication | Jan 20, 2022 |
Notable patents
Publications ranked by popularity score, then publication date.
Pharmaceutical combinations
US-2021386763-A1 · Dec 16, 2021 · US
A triple pharmaceutical combination comprising dabrafenib, trametinib and an erk inhibitor
US-2021121460-A1 · Apr 29, 2021 · US
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
US-10507201-B2 · Dec 17, 2019 · US
Combination of a bcl-2 inhibitor and a mcl-1 inhibitor, uses and pharmaceutical compositions thereof
US-2019240225-A1 · Aug 8, 2019 · US
Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
US-2019231760-A1 · Aug 1, 2019 · US
Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitors
US-2018185341-A1 · Jul 5, 2018 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Novartis Ag | 7 |
| Servier Lab | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 6 |
| A61K2300/00 | 4 |
| A61K31/55 | 4 |
| A61K31/496 | 4 |
| A61K31/519 | 3 |